FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Zimmermann Marc Jason   2. Issuer Name and Ticker or Trading Symbol AMERICAN PHYSICIANS SERVICE GROUP INC [AMPH] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Sr. VP Finance/CFO (Last) (First) (Middle) 1301 S. CAPITAL OF TEXAS HIGHWAY, C-300 3. Date of Earliest Transaction (Month/Day/Year) 11/30/2010 (Street) AUSTIN, TX 78746 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock (1) 11/30/2010   D   4,355 D $ 32.5 (1) 0 D   Common Stock (1) 11/30/2010   D   2,743 D $ 32.5 (1) 0 D   Deferred Stock (2) 11/30/2010   D   13,322 D $ 32.5 (2) 0 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Options	$ 11.55	11/30/2010		D			5,000	(3)	12/07/2010	Common Stock	5,000	$ 20.95 (3)	0	D
Common Stock Options	$ 13.5	11/30/2010		D			10,000	(4)	03/22/2011	Common Stock	10,000	$ 19 (4)	0	D
Common Stock Options	$ 17.36	11/30/2010		D			10,000	(5)	03/23/2012	Common Stock	10,000	$ 15.14 (5)	0	D
Common Stock Options	$ 19.43	11/30/2010		D			10,000	(6)	12/06/2012	Common Stock	10,000	$ 13.07 (6)	0	D
Common Stock Options	$ 20.5	11/30/2010		D			15,000	(7)	09/08/2013	Common Stock	15,000	$ 12 (7)	0	D
Common Stock Options	$ 22.79	11/30/2010		D			20,000	(8)	10/01/2014	Common Stock	20,000	$ 9.71 (8)	0	D
Common Stock Options	$ 24.15	11/30/2010		D			20,000	(9)	06/03/2015	Common Stock	20,000	$ 8.35 (9)	0	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Zimmermann Marc Jason 1301 S. CAPITAL OF TEXAS HIGHWAY C-300 AUSTIN, TX 78746			Sr. VP Finance/CFO

Signatures

/s/ Marc J. Zimmermann		11/30/2010
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Disposed and cancelled 7,098 shares of Common Stock (defined below), including 2,743 shares held by the Issuer's 401(k) Plan, in connection with the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 31, 2010, by and among ProAssurance Corporation, CA Bridge Corporation, and American Physicians Service Group, Inc. (the "Issuer"). Pursuant to such Merger Agreement, each share of common stock of the Issuer, par value $0.10 per share (the "Common Stock") was converted into the right to receive $32.50 in cash and cancelled.
(2)	Disposed and cancelled 13,322 shares of the Issuer's common stock issued under the Issuer's Deferred Compensation Master Plan ("Deferred Stock"). Such Deferred Stock vested immediately prior to the effective time of the Merger pursuant to the Merger Agreement.
(3)	This option, which vested over a three-year period from the date of grant, was cancelled in the Merger in exchange for a cash payment of $104,750, representing the difference between the exercise price of the option and the market value of the underlying Common Stock on the effective date of the Merger ($32.50).
(4)	This option, which provided for vesting on March 22, 2011, vested immediately prior to the effective time of the Merger and was cancelled in the Merger in exchange for a cash payment of $190,000, representing the difference between the exercise price of the option and the market value of the underlying Common Stock on the effective date of the Merger ($32.50).
(5)	This option, which vested over a three-year period from the date of grant, was cancelled in the Merger in exchange for a cash payment of $151,400, representing the difference between the exercise price of the option and the market value of the underlying Common Stock on the effective date of the Merger ($32.50).
(6)	This option, which vested over a three-year period from the date of grant, was cancelled in the Merger in exchange for a cash payment of $130,700, representing the difference between the exercise price of the option and the market value of the underlying Common Stock on the effective date of the Merger ($32.50).
(7)	This option, which vested over a three-year period from the date of grant, was cancelled in the Merger in exchange for a cash payment of $180,000, representing the difference between the exercise price of the option and the market value of the underlying Common Stock on the effective date of the Merger ($32.50).
(8)	This option, which provided for vesting over a three-year period from the date of grant, fully-vested immediately prior to the effective time of the Merger and was cancelled in the Merger in exchange for a cash payment of $194,200, representing the difference between the exercise price of the option and the market value of the underlying Common Stock on the effective date of the Merger ($32.50).
(9)	This option, which provided for vesting over a three-year period from the date of grant, vested immediately prior to the effective time of the Merger and was cancelled in the Merger in exchange for a cash payment of $167,000, representing the difference between the exercise price of the option and the market value of the underlying Common Stock on the effective date of the Merger ($32.50).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.